What are some of the most pressing challenges that we are facing in diabetes health care and education in 2019 and beyond?

What are the major goals that you aim to achieve as a principal officer of the board of directors of the ADA?

As program director of the MedStar Health Diabetes Institute, what new approaches to care have been offered to patients in recent years?

As a long-standing researcher and clinician in diabetes, any reflections on what has changed in recent years and what can be expected in the near future?

What are the major goals that you aim to achieve as a principal officer of the board of directors of the ADA?

You are a well recognized expert in monogenic diabetes with which many physicians may not be familiar? What is monogenic diabetes and how important is diagnostic testing?

What is the overall strategy that the Scientific Sessions Meeting Planning Committee used to develop content for 2019?

What contributions have genetic studies made to the understanding of type 2 diabetes in recent years?

Are there any well recognized differences related to race/ethnicity in type 2 diabetes?